Understanding the Benefits and Risks of Pharmaceuticals

- Workshop Summary

af


Understanding the Benefits and Risks of Pharmaceuticals
Du sparer Spar kr. 45,00 med Shopping-fordele
  • Leveringstid 5-10 hverdage
  • Forventet levering 04-05-2021
For at købe bogen til fordelspris skal du have et medlemskab med Shopping-fordele. Du kan prøve medlemskabet gratis de første 30 dage. Medlemskabet fornyes automatisk og kan altid opsiges. Læs mere om medlemskaber og Shopping-fordele her.
Format:
Bog, paperback
Udgivelsesdato:
14-08-2007
Sprog:
Engelsk
Sidetal:
98
  • Beskrivelse
  • Yderligere info
  • Anmeldelser

All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a limited understanding of the benefits and risks of drugs, and many individuals believe that drugs approved by the U.S. Food and Drug Administration (FDA) carry no risks. The FDA is responsible for evaluating and balancing the potential risks of drugs with their potential benefits. Assessing, managing, and communicating the benefit-risk profile of a pharmaceutical product is a complex and nuanced scientific, political, and sociological challenge. Once the assessment is made, the FDA is then responsible for managing how to communicate these risks and make healthcare decisions based on them. To explore these issues, the Forum on Drug Discovery, Development, and Translation conducted a public workshop entitled Understanding the Benefits and Risks of Pharmaceuticals, with the broad goals of gaining a better understanding of the current system used to evaluate benefit and risk, and to identify opportunities for improvement. This workshop was held in Washington, D.C., on May 30-31, 2006.The benefit-risk profiles of pharmaceuticals are constantly evolving as new data are collected throughout the life cycle of a drug. Discussions during the workshop focused on the following: (1) premarket assessment, during which clinical trial data are used to assess benefit and risk; (2) communication of that information to prescribing physicians and their patients; (3) healthcare decisions made by prescribing physicians and their patients; and (4) the accumulation of benefit-risk information from postmarketing experience, which feeds back into the other phases. Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary explains in detail the discussions during this workshop.

Vis mereVis mindre

Udgivelsesdato:
14-08-2007
ISBN13:
9780309107389
Bredde:
152 mm
Højde:
229 mm
Format:
Paperback

Vis mereVis mindre

Vis mereVis mindre

Fandt du ikke hvad du søgte?

Hvis denne bog ikke er noget for dig, kan du benytte kategorierne nedenfor til at finde andre titler. Klik på en kategori for at se lignende bøger.

Velkommen til Saxo – din danske boghandel!

Hos os kan du handle som gæst, Saxo-bruger eller Premium-medlem – du bestemmer helt selv. Skulle du få brug for hjælp, sidder vores kundeservice-team klar ved både telefonerne og tasterne.

Om fordelspriser hos Saxo

For at købe bøger til fordelspris, skal du være medlem af Premium, Premium Shopping eller Premium Studie. De første 30 dage er gratis for nye medlemmer. Medlemskabet fornyes automatisk og kan altid opsiges. Læs mere om fordelene ved vores forskellige medlemskaber her.

Machine Name: SAXO082